Search Results - Aaron C. Tan

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)

    Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC) by Aaron C. Tan

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers

    Brain Metastases in Lung Cancers with Emerging Targetable Fusion Drivers by Aaron C. Tan, Malinda Itchins, Mustafa Khasraw

    Published 2020
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population

    The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population by Sibo Liu, Nicholas Graves, Aaron C. Tan

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Management of glioblastoma: State of the art and future directions

    Management of glioblastoma: State of the art and future directions by Aaron C. Tan, David M. Ashley, Giselle Y. López, Michael D. Malinzak, Henry S. Friedman, Mustafa Khasraw

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma

    FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma by Florentia Dimitriou, Serigne Lo, Aaron C. Tan, Louise Emmett, Rony Kapoor, Matteo S. Carlino, Georgina V. Long, Alexander M. Menzies

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma

    FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma by Aaron C. Tan, Louise Emmett, Serigne Lo, V. Liu, Rony Kapoor, Matteo S. Carlino, Alexander Guminski, Georgina V. Long, Alexander M. Menzies

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts

    The Paradoxical Effects of COVID-19 on Cancer Care: Current Context and Potential Lasting Impacts by Alex Broom, Katherine Kenny, Alexander Page, Nicole Cort, Eric Lipp, Aaron C. Tan, David M. Ashley, Kyle M. Walsh, Mustafa Khasraw

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC

    Intratumoral CD39+CD8+ T Cells Predict Response to Programmed Cell Death Protein-1 or Programmed Death Ligand-1 Blockade in Patients With NSCLC by Joe Yeong, Lisda Suteja, Yannick Simoni, Kah Weng Lau, Aaron C. Tan, Hui Hua Li, Sherlly Lim, Jie Hua Loh, Felicia Wee, Sanjna Nilesh Nerurkar, Angela Takano, Eng Huat Tan, Tony Kiat Hon Lim, Evan W. Newell, Daniel S.W. Tan

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Systematic review of combinations of targeted or immunotherapy in advanced solid tumors

    Systematic review of combinations of targeted or immunotherapy in advanced solid tumors by Aaron C. Tan, Stephen Bagley, Patrick Y. Wen, Michael Lim, Michael Platten, Howard Colman, David M. Ashley, Wolfgang Wick, Susan M. Chang, Evanthia Galanis, Alireza Mansouri, Simon Khagi, Minesh P. Mehta, Amy B. Heimberger, Vinay K. Puduvalli, David A. Reardon, Solmaz Sahebjam, John Simes, Scott Antonia, Don Berry, Mustafa Khasraw

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer

    Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer by W. Marston Linehan, Stephen V. Liu, Caroline E. McCoach, Viola W. Zhu, Aaron C. Tan, Satoshi Yoda, Jennifer Peterson, Andrew Do, Kylie Prutisto-Chang, Ibiayi Dagogo‐Jack, Lecia V. Sequist, Lori J. Wirth, Jochen K. Lennerz, Aaron N. Hata, Mari Mino‐Kenudson, Valentina Nardi, S.-H.I. Ou, Daniel Shao-Weng Tan, Justin F. Gainor

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group

    Recommendations for the use of next-generation sequencing in patients with metastatic cancer in the Asia-Pacific region: a report from the APODDC working group by Herbert H. Loong, Toshio Shimizu, Amy Prawira, Aaron C. Tan, Ben Tran, Daphne Day, David S.P. Tan, Frederic Ivan L. Ting, Joanne Chiu, Mun N. Hui, Michelle Wilson, Naiyarat Prasongsook, Takafumi Koyama, Thanyanan Reungwetwattana, Tira J. Tan, Valerie Heong, Pei Jye Voon, Sehhoon Park, Iain Beehuat Tan, Stephen L. Chan, Daniel S.W. Tan

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  12. 12
    Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC

    Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC by Aaron C. Tan, A. Seet, Gillianne Lai, Tse Hui Lim, Alvin S.T. Lim, Gek San Tan, Angela Takano, David Tai, Tira J. Tan, Justina Yick Ching Lam, Matthew Chau Hsien Ng, Wan Ling Tan, Mei‐Kim Ang, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Tanujaa Rajasekaran, Wan‐Teck Lim, Eng-Huat Tan, Tony Kiat Hon Lim, Daniel S.W. Tan

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung cancer

    Detection of circulating tumor DNA with ultradeep sequencing of plasma cell‐free DNA for monitoring minimal residual disease and early detection of recurrence in early‐stage lung c... by Aaron C. Tan, Gillianne Lai, Stephanie P.L. Saw, Kevin Lee Min Chua, Angela Takano, Boon‐Hean Ong, Tina Koh, Amit Jain, Wan Ling Tan, Quan Sing Ng, Ravindran Kanesvaran, Tanujaa Rajasekaran, Ekaterina Kalashnikova, Derrick Renner, Sumedha Sudhaman, Meenakshi Malhotra, Himanshu Sethi, Minetta C. Liu, Alexey Aleshin, Wan‐Teck Lim, Eng‐Huat Tan, Anders J. Skanderup, Mei‐Kim Ang, Daniel S.W. Tan

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer

    Association of Clinicopathologic and Molecular Tumor Features With Recurrence in Resected Early-Stage Epidermal Growth Factor Receptor–Positive Non–Small Cell Lung Cancer by Stephanie P.L. Saw, Siqin Zhou, Jianbin Chen, Gillianne Lai, Mei‐Kim Ang, Kevin Lee Min Chua, Ravindran Kanesvaran, Quan Sing Ng, Amit Jain, Wan Ling Tan, Tanujaa Rajasekaran, Wan‐Teck Lim, Aaron C. Tan, Kam Weng Fong, Angela Takano, Xin Cheng, Kiat Hon Lim, Tina Koh, Boon‐Hean Ong, Eng Huat Tan, Chee‐Keong Toh, Anders J. Skanderup, Sze Huey Tan, Daniel Shao-Weng Tan

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

    Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer by Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou, Siraj M. Ali, D. Lucas Kerr, Victor Olivas, Jonathan Shue, Julia Rotow, Manasi K. Mayekar, Franziska Haderk, Nilanjana Chatterjee, Anatoly Urisman, Jia Chi Yeo, Anders J. Skanderup, Aaron C. Tan, Wai Leong Tam, Óscar Arrieta, Kazuyoshi Hosomichi, Akihiro Nishiyama, Seiji Yano, Yuriy Kirichok, Daniel S.W. Tan, Rafael Rosell, Ross A. Okimoto, Trever G. Bivona

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Why Calls for More Routine Carotid Stenting Are Currently Inappropriate

    Why Calls for More Routine Carotid Stenting Are Currently Inappropriate by Anne L. Abbott, Mark A. Adelman, Andrei V. Alexandrov, P. Alan Barber, Henry J.M. Barnett, Jonathan Beard, Peter Bell, Martin Björck, David Blacker, Leo H. Bonati, Martin M. Brown, Clifford J. Buckley, Richard P. Cambria, John Castaldo, Anthony J. Comerota, E. Sander Connolly, Ronald L. Dalman, Alun H. Davies, Hans‐Henning Eckstein, Rishad M. Faruqi, Thomas E. Feasby, Gustav Fraedrich, Péter Gloviczki, Graeme J. Hankey, Robert E. Harbaugh, Eitan Heldenberg, Michael G. Hennerici, Michael D. Hill, Timothy Kleinig, Dimitri P. Mikhailidis, Wesley S. Moore, Ross Naylor, Andrew Nicolaides, Kosmas I. Paraskevas, David M. Pelz, James W. Prichard, Grant Purdie, Jean‐Baptiste Ricco, Peter A. Ringleb, Thomas S. Riles, Peter M. Rothwell, Peter Sandercock, Henrik Sillesen, J. David Spence, Francesco Spinelli, Jonathon Sturm, Aaron C. Tan, Ankur Thapar, Frank J. Veith, Tissa Wijeratne, Wei Zhou

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: